BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30558566)

  • 21. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
    Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
    Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation.
    Szalai E; Jiang Y; van Poppelen NM; Jager MJ; de Klein A; Kilic E; Grossniklaus HE
    JAMA Ophthalmol; 2018 Oct; 136(10):1115-1120. PubMed ID: 30073324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in prognostic and predictive testing in uveal melanoma.
    Field MG; Harbour JW
    Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.
    Küsters-Vandevelde HV; van Engen-van Grunsven IA; Coupland SE; Lake SL; Rijntjes J; Pfundt R; Küsters B; Wesseling P; Blokx WA; Groenen PJ
    Pathol Oncol Res; 2015 Apr; 21(2):439-47. PubMed ID: 25315378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.
    Drabarek W; Yavuzyigitoglu S; Obulkasim A; van Riet J; Smit KN; van Poppelen NM; Vaarwater J; Brands T; Eussen B; Verdijk RM; Naus NC; Mensink HW; Paridaens D; Boersma E; van de Werken HJG; Kilic E; de Klein A;
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3595-3605. PubMed ID: 31425584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
    Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
    PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
    Robertson AG; Shih J; Yau C; Gibb EA; Oba J; Mungall KL; Hess JM; Uzunangelov V; Walter V; Danilova L; Lichtenberg TM; Kucherlapati M; Kimes PK; Tang M; Penson A; Babur O; Akbani R; Bristow CA; Hoadley KA; Iype L; Chang MT; ; Cherniack AD; Benz C; Mills GB; Verhaak RGW; Griewank KG; Felau I; Zenklusen JC; Gershenwald JE; Schoenfield L; Lazar AJ; Abdel-Rahman MH; Roman-Roman S; Stern MH; Cebulla CM; Williams MD; Jager MJ; Coupland SE; Esmaeli B; Kandoth C; Woodman SE
    Cancer Cell; 2017 Aug; 32(2):204-220.e15. PubMed ID: 28810145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New concepts in the molecular understanding of uveal melanoma.
    Reichstein D
    Curr Opin Ophthalmol; 2017 May; 28(3):219-227. PubMed ID: 28257297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular profiling of primary uveal melanoma: results of a Polish cohort.
    Kowalik A; Karpinski P; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P; Hoang MP
    Melanoma Res; 2023 Apr; 33(2):104-115. PubMed ID: 36719926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic genomic and translational efficiency studies of uveal melanoma.
    Johnson CP; Kim IK; Esmaeli B; Amin-Mansour A; Treacy DJ; Carter SL; Hodis E; Wagle N; Seepo S; Yu X; Lane AM; Gragoudas ES; Vazquez F; Nickerson E; Cibulskis K; McKenna A; Gabriel SB; Getz G; Van Allen EM; 't Hoen PAC; Garraway LA; Woodman SE
    PLoS One; 2017; 12(6):e0178189. PubMed ID: 28594900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.
    Mudhar HS; Doherty R; Salawu A; Sisley K; Rennie IG
    Br J Ophthalmol; 2013 Jul; 97(7):924-8. PubMed ID: 23685997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paired comparisons of mutational profiles before and after brachytherapy in asian uveal melanoma patients.
    Lee WS; Lee J; Choi JJ; Kang HG; Lee SC; Kim JH
    Sci Rep; 2021 Sep; 11(1):18594. PubMed ID: 34545149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
    Sheng X; Kong Y; Li Y; Zhang Q; Si L; Cui C; Chi Z; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Dai J; Guo J
    Eur J Cancer; 2016 Sep; 65():156-63. PubMed ID: 27498141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.